BKM1644 exhibits potent anticancer activity; effectively inhibits the proliferation of metastatic castration-resistant prostate cancer (mCRPC) cells; sensitizes mCRPC cells to docetaxel (HY-B0011); and delays the growth of prostate cancer bone metastases.